NCCN Guidelines for Patients® | Multiple Myeloma - page 44

42
NCCN Guidelines for Patients
®
Multiple Myeloma, Version 1.2014
4.2 Solitary plasmacytoma
Chart 4.2
shows the recommended primary
treatment options for a solitary plasmacytoma. A
solitary plasmacytoma is when there is only a single
mass of myeloma cells. The chart also shows the
follow-up tests that are recommended after primary
treatment.
Primary treatment is the first or main treatment given
to rid the body of cancer. Treatment options are based
on where the solitary plasmacytoma is located in the
body. An osseous solitary plasmacytoma begins in
bone marrow. An extraosseous solitary plasmacytoma
begins in soft tissue outside the bone.
Primary treatment
Because there is only one cancer mass in a solitary
plasmacytoma, treatment includes radiation, a local
therapy. For an extraosseous plasmacytoma, another
option is to remove the mass with surgery. (See Part
3 on page 24 for more details about each treatment.)
Follow-up tests
After completing primary treatment for a solitary
plasmacytoma, you will have follow-up tests to check
how well treatment worked. These tests are used
4
Treatment guide
Solitary plasmacytoma
Cancer type
Primary treatment
Follow-up tests
Solitary
osseous
plasmacytoma
Chart 4.2 Primary treatment and follow-up for solitary plasmacytoma
Solitary
extraosseous
plasmacytoma
Radiation therapy
Radiation therapy,
Surgery, or
Both
• Bone marrow aspiration and biopsy as needed
Blood tests
• CBC
• Creatinine, albumin, and calcium
• LDH as needed
• Beta-2 microglobulin as needed
• Serum free light chain assay
• Serum quantitative immunoglobulins
• SPEP and SIFE
Urine tests
• Total protein
• UPEP and UIFE
Imaging tests
• Bone survey as needed or every year
• MRI, CT, PET/CT as needed
1...,34,35,36,37,38,39,40,41,42,43 45,46,47,48,49,50,51,52,53,54,...82
Powered by FlippingBook